Junevity is a biotechnology company developing cell reprogramming therapeutics with siRNA. The Junevity RESET platform is the first to use human disease omics, genetic linkages and ML/AI to identify novel transcription factor targets and repress them with siRNA therapeutics. Initial programs are in metabolism and neurodegeneration.
Leadership & Board
Current Number of Employees13
Current LinkedIn Followers2,468
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Junevity had 13 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
13Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Junevity had 2,468 followers as of September 14, 2026. The number of followers increased by 9 (0.37%) week-over-week.
2,468Latest Followers Count
9(0.37%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.